Robert Hood on Muck Rack

Robert Hood

Seattle
As seen in: Environmental Health Perspectives, Nature, Bandcamp Daily, Medscape, The San Diego Union-Tribune, UCSF Synapse, American Journal of Public Health, Fred Hutch News Service, HospitalityNet, Juno Daily and
Photography multimedia, motorcycle rider, Americana music fan
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Robert

Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Dr. Hans-Peter Kiem receives ASGCT mentorship award

|
By Robert Hood
| Fred Hutch News Service
Facebook LinkedIn Twitter Email Bluesky Fred Hutch gene therapy expert views mentorship as a lifelong commitment Dr. Hans-Peter Kiem, recent recipient of the American Society of Gene and Cell Therapy's George Stamatoyannopoulos Mentorship Award, discusses why mentorship programs are important in a scientific research and medical setting.
Open in Who Shared Issue with article?

What’s the psychology behind using dietary supplements?

|
By Diane Mapes, Robert Hood
| Fred Hutch News Service
Transcript: Diane Mapes (00:01) Hi, I’m Diane Mapes with Fred Hutch News. I recently wrote about dietary supplements and how studies, many of them done at Fred Hutch, have shown they’re not necessarily good for cancer prevention and in some cases can even promote cancer. It made me curious as to why we tend to reach for pills or powders or peptides, this new trend of biohacking, but we turn away from more science-based interventions like vaccines.
Open in Who Shared View Duplicates (2) Issue with article?

Scientists see foam as starting point of a path to bedside gene therapy

|
By Sabrina Richards , Robert Hood
| Fred Hutch News Service
Currently, a patient receiving gene therapy to correct sickle cell disease can expect to devote about a year to their treatment. After their bone marrow stem cells are harvested, the process during which they are cultured and genetically engineered takes about six months. From the blood stem cell’s perspective, it’s an inefficient process, Stephan said. “Most of [the stem cells] don’t make it.
Open in Who Shared Issue with article?
See all 106 licensed articles (109 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Robert

Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified